Advertisement

Topics

Pfizer Prices $1,065,000,000 Debt Offering

13:09 EST 24 Feb 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Pfizer Inc. (NYSE: PFE) today announced the pricing of $1,065,000,000 aggregate principal amount of 4.20% notes due 2047. This offering is expected to be sold to professional institutional investors in Taiwan, with application t...

Other Sources for this Article

Pfizer Inc.
Media Relations:
Joan Campion, 212-733-2798
or
Investor Relations:
Ryan Crowe, 212-733-8160

NEXT ARTICLE

More From BioPortfolio on "Pfizer Prices $1,065,000,000 Debt Offering"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Pfizer
Pfizer is a global pharmaceutical company, the largest in world based on annual sales.  In 2009, annual sales were worth $45,448m. Pfizer spend £550m on R&D in the UK alone, and have colleagues in 180 countries. Lipitor, one of its produ...